Related Experiment Video
Updated: Oct 9, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
The Use of Auto-Titrating Continuous Positive Airway Pressure (AutoCPAP) for Obstructive Sleep Apnea Syndrome in
Sarah Benke1, Caroline U A Okorie2, MaryAnne A Tablizo2,3
1Department of Pediatrics, Valley Children's Hospital, Madera, CA 93636, USA.
Insights
Auto-adjusting positive airway pressure (autoCPAP) is a safe and effective treatment for children with obesity and obstructive sleep apnea syndrome (OSAS). This therapy significantly reduced apnea events, showing promise for timely intervention.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Obesity Medicine
Background:
- Obstructive Sleep Apnea Syndrome (OSAS) affects children, with positive airway pressure therapy being a common treatment.
- Limited research exists on the efficacy and safety of auto-adjusting positive airway pressure (autoCPAP) in obese pediatric populations.
Purpose of the Study:
- To evaluate the safety and effectiveness of autoCPAP in treating pediatric patients with obesity and OSAS.
- To compare autoCPAP adherence and pressure settings with traditional PAP titration.
Main Methods:
- Retrospective chart review of children (ages 2-18) with obesity (BMI > 99th percentile) diagnosed with OSAS.
- Analysis of 30-day autoCPAP adherence and comparison of baseline Obstructive Apnea-Hypopnea Index (OAHI) with post-treatment AHI.
- Comparison of autoCPAP 95th percentile pressures with PAP titration pressures.
Main Results:
- 19 children (ages 5-15) with a median BMI of 99.6th percentile were included.
- Average autoCPAP adherence was 25/30 nights, with a mean use of 7.3 hours/night.
- Median OAHI decreased from 12.3/h to 1.7/h, with no reported adverse outcomes. AutoCPAP pressures closely matched PAP titration pressures.
Conclusions:
- AutoCPAP appears to be an effective and safe treatment for OSAS in pediatric patients with obesity.
- This therapy may expedite treatment initiation for this population.
- Further research is warranted to confirm long-term autoCPAP effectiveness in pediatric obesity.
Background:
Positive airway pressure can be an effective and safe therapy for children with obstructive sleep apnea syndrome (OSAS). Few studies have assessed the safety and efficacy of autoCPAP in pediatric patients with obesity.
Methods:
This was a retrospective chart review of children with obesity (Body Mass Index (BMI) > 99th percentile), ages 2-18, diagnosed with OSAS (Obstructive Apnea-Hypopnea Index (OAHI) > 1/h) and used autoCPAP with 30-day adherence. Exclusion criteria included patients with complex comorbidities. Adherence was defined as autoCPAP use ≥4 h/night for at least 21/30 days. Baseline PSG OAHI was compared to the AHI from the 30-day autoCPAP compliance report. We also compared autoCPAP 30-day 95th percentile pressures with the pressures from PAP titration.
Results:
The study included 19 children, ranging 5-15 years old. The median BMI was 99.6th percentile and average adherence was 25/30 nights with mean of 7.3 h/night. The median OAHI was 12.3/h on baseline PSG and the 30-day autoCPAP download AHI decreased to 1.7/h. No adverse outcomes were identified. The average difference between 95th percentile autoCPAP pressure and PAP titration pressure was 0.89 cmH20.
Conclusion:
Our study suggests autoCPAP is effective and safe for the treatment of OSAS in pediatric patients with obesity. Using autoCPAP may reduce delays in treatment. Additional research is needed to verify the long-term effectiveness of autoCPAP in this population.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Drug Dosing: Obese Patients
COPD: Management Using Bronchodilators and Corticosteroids

